Overview
Yanjin He practices practicing medicine in Changhongjie, China.
He is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Lacrimal Gland Tumor, Adenoid Cystic Carcinoma, Retinoblastoma, and Dacryoadenitis.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yanjin He
Is Yanjin He a top-rated expert for Lacrimal Gland Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Yanjin He is classified as an Advanced expert for Lacrimal Gland Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yanjin He participate in research or clinical trials?
Yes. Yanjin He has published 15 articles and abstracts on conditions like Lacrimal Gland Tumor. You can view a list of Yanjin He's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adenoid Cystic Carcinoma
- Lacrimal Gland Tumor
- Experienced
- Bone TumorHe isExperienced. Learn about Bone Tumor.
- DacryoadenitisHe isExperienced. Learn about Dacryoadenitis.
- RetinoblastomaHe isExperienced. Learn about Retinoblastoma.